Finance

Lists
URGN:NASDAQ
Urogen Pharma Ltd
$ 38.26
-0.05%
(-0.020) 1D
$ 38.26
0.00% (0.00)
After hours
Closed: 10-р сарын 13, 16:00:00 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for URGN...
Open
$ 37.82
High
$ 38.84
Low
$ 37.30
Mkt. cap
1.87 тэрбум
Avg. vol.
886.98 мян
Volume
0.00
52-wk high
$ 50.81
52-wk low
$ 16.27
EPS
-$ 1.98
Beta
1.57
Shares outstanding
48.88 сая
No. of employees
300
Open
$ 37.82
High
$ 38.84
Low
$ 37.30
Mkt. cap
1.87 тэрбум
Avg. vol.
886.98 мян
Volume
0.00
52-wk high
$ 50.81
52-wk low
$ 16.27
EPS
-$ 1.98
Beta
1.57
Shares outstanding
48.88 сая
No. of employees
300
News stories
From web sources and news partners
Seeking Alpha
Seeking Alpha
·
23 цагийн өмнө
UroGen Pharma: An Emerging GARP Stock
About Urogen Pharma Ltd
CEO-
Employees300
Founded2004
HeadquartersНью-Йорк хот, Нью-Йорк Муж Улс, Америкийн Нэгдсэн Улс
Sector-
Websiteurogen.com
Analyst ratings
Based on 5 analysts giving stock ratings to URGN in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for URGN in the last 3 months.
Highest
Current $ 38.26
$ 75.00 (+96.03%)
Average
$ 60.20 (+57.34%)
Lowest
$ 48.00 (+25.46%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$ 75.00
+96%
08/21/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
$ 60.00
+56.8%
08/06/2026
Paul Choi
Goldman Sachs
Hold
Maintained
$ 48.00
+25.5%
08/05/2026
Michael Schmidt
Guggenheim
Buy
Maintained
$ 58.00
+51.6%
08/05/2026
Tara Bancroft
TD Cowen
Buy
Reiterated
$ 60.00
+56.8%
08/05/2026
Unknown Analyst
Guggenheim
Buy
Maintained
$ 32.00
-16.4%
06/03/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Initiated
$ 43.00
+12.4%
05/11/2026
Kelsey Goodwin
Piper Sandler
Buy
Maintained
$ 40.00
+4.5%
04/20/2026
Amin Makarem
Jefferies
Buy
Initiated
$ 40.00
+4.5%
04/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
27.48 сая
37.84 сая
50.96 сая
72.46 сая
Cost of goods sold
3.28 сая
3.29 сая
4.14 сая
6.57 сая
Cost of revenue
3.28 сая
3.29 сая
4.14 сая
6.57 сая
Research and development expenses
14.01 сая
14.31 сая
15.60 сая
17.34 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37.58 сая
39.35 сая
51.49 сая
48.44 сая
Operating expense
51.59 сая
53.66 сая
67.08 сая
65.77 сая
Total operating expenses
54.87 сая
56.95 сая
71.22 сая
72.34 сая
Operating income
-27.39 сая
-19.12 сая
-20.26 сая
111.00 мян
Other non operating income
-4.82 сая
-4.66 сая
-4.83 сая
-4.89 сая
EBT including unusual items
-34.40 сая
-26.64 сая
-28.35 сая
-8.72 сая
EBT excluding unusual items
-34.40 сая
-26.64 сая
-28.35 сая
-8.72 сая
Income tax expense
-1.05 сая
-275.00 мян
-4.77 сая
5.63 сая
Effective tax rate
3.06%
1.03%
16.83%
-64.54%
Other operating expenses
-
-
-
-
Net income
-33.35 сая
-26.36 сая
-23.57 сая
-14.35 сая
Net profit margin
-121.34%
-69.68%
-46.26%
-19.81%
Earnings per share
-0.69
-0.53
-0.47
-0.28
Interest and investment income
1.18 сая
908.00 мян
931.00 мян
946.00 мян
Interest expense
-3.37 сая
-3.77 сая
-4.18 сая
-4.89 сая
Net interest expenses
-2.20 сая
-2.86 сая
-3.25 сая
-3.94 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.31 сая
-19.04 сая
-20.19 сая
189.00 мян
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс